Omeros Corp. Stock
Omeros Corp. Stock
There is an upward development for Omeros Corp. compared to yesterday, with an increase of €0.038 (1.350%).
Our community identified positive and negative aspects for Omeros Corp. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Omeros Corp. stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.
Pros and Cons of Omeros Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omeros Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Omeros Corp. | 1.350% | -10.121% | -9.371% | -45.377% | -9.892% | -81.098% | -82.705% |
Ardelyx Inc. | 0.130% | -4.466% | -13.831% | 35.956% | 5.848% | -10.686% | - |
Salarius Pharmaceuticals Inc. | 0.950% | -2.778% | -19.231% | -68.421% | -24.324% | -98.250% | -99.994% |
Brainstorm Cell | 1.170% | -0.586% | 0.792% | -81.287% | 119.397% | -80.271% | - |
Comments
Omeros Co. (NASDAQ: OMER) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for OMER provided by MarketBeat
Omeros Co. (NASDAQ: OMER) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for OMER provided by MarketBeat
Omeros Co. (NASDAQ: OMER) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OMER provided by MarketBeat